Polyethylene Glycol and Tofacitinib Extended-Release Tablets
Determining the interaction of Polyethylene Glycol and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: polyethylene glycol 3350
Brand name: ClearLax, GaviLAX, Gialax, GlycoLax, MiraLAX, PEG3350, SunMark ClearLax, HealthyLax, GaviLAX, MiraLAX
Synonyms: Polyethylene glycol 3350, Polyethylene Glycol 3350
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Polyethylene Glycol-Tofacitinib Tablets
- Polyethylene Glycol-Tofranil
- Polyethylene Glycol-Tofranil injection
- Polyethylene Glycol-Tofranil-PM
- Polyethylene Glycol-Tol-Tab
- Polyethylene Glycol-Tolazamide
- Tofacitinib Extended-Release Tablets-Polyethylene glycol 3350
- Tofacitinib Extended-Release Tablets-Polyethylene glycol 3350 and electrolytes
- Tofacitinib Extended-Release Tablets-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Tofacitinib Extended-Release Tablets-Polyethylene glycol 3350, sodium and potassium salts
- Tofacitinib Extended-Release Tablets-Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride
- Tofacitinib Extended-Release Tablets-Polyethylene glycol electrolyte solution